MD

Matthew Ryan Dumont

Board Member at Veloxis Pharmaceuticals

Mr. Dumont joined Asahi Kasei Pharma America in April 2019 as Director of Corporate Development. Mr. Dumont has 10 years of commercial experience in business and corporate development within the biopharmaceutical and medical device industries. Prior to joining Asahi Kasei, Mr. Dumont was Director of Strategy and Corporate Development at PerkinElmer, Inc. In addition, Mr. Dumont has held corporate development roles at Mylan Pharmaceuticals and Catalent Pharma Solutions. Mr. Dumont holds a Bachelor and Masters of Science in Chemical Engineering from the Johns Hopkins University and a Master of Business Administration from Columbia University.

Matthew Ryan Dumont will be an independent board member.

Timeline

  • Board Member

    Current role